Next Article in Journal
Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients
Previous Article in Journal
Increased Extracellular Matrix Protein Production in Chronic Diabetic Complications: Implications of Non-Coding RNAs
Article Menu

Article Menu

Project Report

Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129

Cardiovascular Research Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg
Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary
Department of Intelligent Systems, Jozef Stefan Institute, 1000e Ljubljana, Slovenia
Department of Medical Biology, Faculty of Medicine, Cumhuriyet University, 58140 Sivas, Turkey
Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK
Institute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 84104 Bratislava, Slovakia
Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece
Integrated BioBank of Luxembourg, L-3550 Dudelange, Luxembourg
Faculty of Health Sciences, University of Malta, MSD 2080 Msida, Malta
Faculty of Technology and Metallurgy, University of Belgrade, 11000 Belgrade, Serbia
Department Cardiovascular, Humanitas Research Hospital, 20089 Rozzano, Italy
Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, PB 4956 Nydalen, NO-0424 Oslo, Norway
Firalis, 68330 Huningue, France
Institute of Biomedical Research of Barcelona (IIBB)—Spanish National Research Council (CSIC), 08036 Barcelona, Spain
Mental Health Center Sct. Hans, 4000 Roskilde, Denmark
Instituto de Medicina Molecular, Faculty Medicine, University Lisboa, 1649-028 Lisboa, Portugal
Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, 2417 Nicosia, Cyprus
Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria
TAmiRNA, 1190 Vienna, Austria
Faculty of Engineering and Natural Sciences, International University of Sarajevo, 71210 Sarajevo, Bosnia and Herzegovina
Biogazelle, 9052 Zwijnaarde, Belgium
School for Cardiovascular Diseases, Faculty Health, Medicine and Life Sciences, Maastricht University, 6229ER Maastricht, The Netherlands
Department of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, 142 20 Prague, Czech Republic
Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU Norwegian University of Technology and Science, NO-7489 Trondheim, Norway
Department of Physiology, Institute for Biological Research “Siniša Stanković,” University of Belgrade, 11000 Belgrade, Serbia
Department of Biology, Faculty of Natural Sciences and Mathematics, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina
Department of Basic Sciences, University of Crete Medical School and Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology of Hellas, Heraklion 71003, Crete, Greece
Research Unit of Biomedicine, University of Oulu, 90014 Oulu, Finland
Department of Biomedicine and Clinic of Cardiology, University Hospital and University of Basel, 4031 Basel, Switzerland
Minerva Institute for Medical Research, 00290 Helsinki, Finland
The Cardinal Stefan Wyszynski Institute of Cardiology, 04-628 Warsaw, Poland
Center for Molecular Medicine, Karolinska Institute, 17176 Stockholm, Sweden
Molecular Cardiology Laboratory, IRCCS-Policlinico San Donato, 20097 San Donato Milanese, Milan, Italy
Department of Physiology, University of Valencia and INCLIVA Biomedical Research Institute INCLIVA, 46010 Valencia, Spain
Regenerative Medicine Institute REMEDI, National University of Ireland Galway (NUIG), H91 TK33 Galway, Ireland
Experimental Cardiology Unit, Division of Cardiology, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011 Lausanne, Switzerland
INSERM, Institut Pasteur de Lille, 59019 Lille Cedex, France
Babes-Bolyai University, 400084 Cluj-Napoca, Romania
University Hospital Centre Sisters of Charity, Institute for clinical medical research and education, 10 000 Zagreb, Croatia
Department of Cardiology, Centre for Heart Failure Research, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands
Institute for Drug Research, Faculty of Medicine, The Hebrew University, 91120 Jerusalem, Israel
Institute for Medical Informatics, Statistics and Epidemiology IMISE, Medical Faculty, University of Leipzig, 04107 Leipzig, Germany
Institute of Cellular Biology and Pathology “Nicolae Simionescu”, 050568 Bucharest, Romania
Westfälische Wilhelms-Universität Münster, Institute of Human Genetics, Department of Genetic Epidemiology, 48149 Münster, Germany
International Clinical Research Center, 656 91 Brno, Czech Republic
Dokuz Eylul University, Faculty of Medicine, Department of Cardiology, 35340 Izmir, Turkey
National Heart & Lung Institute, Faculty of Medicine, Imperial College London, London W12 0HH, UK
Author to whom correspondence should be addressed.
Non-Coding RNA 2019, 5(2), 31;
Received: 7 March 2019 / Revised: 25 March 2019 / Accepted: 26 March 2019 / Published: 29 March 2019
Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks ( View Full-Text
Keywords: cardiovascular disease; transcriptomics; best practices and guidelines; translational research; personalized medicine cardiovascular disease; transcriptomics; best practices and guidelines; translational research; personalized medicine
Show Figures

Figure 1

MDPI and ACS Style

Gomes, C.P.d.C.; Ágg, B.; Andova, A.; Arslan, S.; Baker, A.; Barteková, M.; Beis, D.; Betsou, F.; Bezzina Wettinger, S.; Bugarski, B.; Condorelli, G.; da Silva, G.J.J.; Danilin, S.; de Gonzalo-Calvo, D.; Buil, A.; Carmo-Fonseca, M.; Enguita, F.J.; Felekkis, K.; Ferdinandy, P.; Gyöngyösi, M.; Hackl, M.; Karaduzovic-Hadziabdic, K.; Hellemans, J.; Heymans, S.; Hlavackova, M.; Hoydal, M.A.; Jankovic, A.; Jusic, A.; Kardassis, D.; Kerkelä, R.; Kuster, G.M.; Lakkisto, P.; Leszek, P.; Lustrek, M.; Maegdefessel, L.; Martelli, F.; Novella, S.; O’Brien, T.; Papaneophytou, C.; Pedrazzini, T.; Pinet, F.; Popescu, O.; Potočnjak, I.; Robinson, E.; Sasson, S.; Scholz, M.; Simionescu, M.; Stoll, M.; Varga, Z.V.; Vinciguerra, M.; Xuereb, A.; Yilmaz, M.B.; Emanueli, C.; Devaux, Y. Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129. Non-Coding RNA 2019, 5, 31.

AMA Style

Gomes CPdC, Ágg B, Andova A, Arslan S, Baker A, Barteková M, Beis D, Betsou F, Bezzina Wettinger S, Bugarski B, Condorelli G, da Silva GJJ, Danilin S, de Gonzalo-Calvo D, Buil A, Carmo-Fonseca M, Enguita FJ, Felekkis K, Ferdinandy P, Gyöngyösi M, Hackl M, Karaduzovic-Hadziabdic K, Hellemans J, Heymans S, Hlavackova M, Hoydal MA, Jankovic A, Jusic A, Kardassis D, Kerkelä R, Kuster GM, Lakkisto P, Leszek P, Lustrek M, Maegdefessel L, Martelli F, Novella S, O’Brien T, Papaneophytou C, Pedrazzini T, Pinet F, Popescu O, Potočnjak I, Robinson E, Sasson S, Scholz M, Simionescu M, Stoll M, Varga ZV, Vinciguerra M, Xuereb A, Yilmaz MB, Emanueli C, Devaux Y. Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129. Non-Coding RNA. 2019; 5(2):31.

Chicago/Turabian Style

Gomes, Clarissa Pedrosa da Costa, Bence Ágg, Andrejaana Andova, Serdal Arslan, Andrew Baker, Monika Barteková, Dimitris Beis, Fay Betsou, Stephanie Bezzina Wettinger, Branko Bugarski, Gianluigi Condorelli, Gustavo José Justo da Silva, Sabrina Danilin, David de Gonzalo-Calvo, Alfonso Buil, Maria Carmo-Fonseca, Francisco J. Enguita, Kyriacos Felekkis, Peter Ferdinandy, Mariann Gyöngyösi, Matthias Hackl, Kanita Karaduzovic-Hadziabdic, Jan Hellemans, Stephane Heymans, Markéta Hlavackova, Morten Andre Hoydal, Aleksandra Jankovic, Amela Jusic, Dimitris Kardassis, Risto Kerkelä, Gabriela M. Kuster, Päivi Lakkisto, Przemyslaw Leszek, Mitja Lustrek, Lars Maegdefessel, Fabio Martelli, Susana Novella, Timothy O’Brien, Christos Papaneophytou, Thierry Pedrazzini, Florence Pinet, Octavian Popescu, Ines Potočnjak, Emma Robinson, Shlomo Sasson, Markus Scholz, Maya Simionescu, Monika Stoll, Zoltan V. Varga, Manlio Vinciguerra, Angela Xuereb, Mehmet Birhan Yilmaz, Costanza Emanueli, and Yvan Devaux. 2019. "Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129" Non-Coding RNA 5, no. 2: 31.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop